Inogen, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)

6 Months Ended

Jun. 30, 2020

The activity for stock options under the Company’s stock plans for the six months ended June 30, 2020 is as follows:

								Remaining
								weighted-
						Weighted-		average		Per share
						average		contractual		average
				Price per		exercise		terms		intrinsic
	Options			share		price		(in years)		value
Outstanding as of December 31, 2019		980,884		$0.75-$83.30		$	35.24		2.84	$	34.07
Granted		—			—		—
Exercised		(9,324	)	1.17-44.19			20.00
Forfeited		(3,784	)	44.19-56.72			51.44
Expired		—			—		—
Outstanding as of June 30, 2020		967,776		0.75-83.30			35.33		2.34		7.62
Vested and exercisable as of June 30, 2020		967,776		0.75-83.30			35.33		2.34		7.62
Vested and expected to vest as of June 30, 2020		967,776		$0.75-$83.30		$	35.33		2.34	$	7.62

Summary of Restricted Stock Activity

Stock Awards activity for the six months ended June 30, 2020 is summarized below:

										Weighted-
										average
										grant
				Performance						date fair
				and						value
Restricted stock units	Time-based			time-based			Total			per share
Unvested restricted stock units as of December 31, 2019		108,976			3,134			112,110		$	83.48
Granted		181,313			88,458			269,771			44.88
Vested		(30,484	)		—			(30,484	)		88.71
Forfeited/canceled		(13,519	)		(3,134	)		(16,653	)		81.50
Unvested restricted stock units as of June 30, 2020 ⁽¹⁾		246,286			88,458			334,744		$	52.68
Unvested and expected to vest restricted stock units outstanding as of June 30, 2020								247,317		$	53.74

										Weighted-
										average
										grant
				Performance						date fair
				and						value
Restricted stock awards	Time-based			time-based			Total			per share
Unvested restricted stock awards outstanding as of December 31, 2019		71,070			62,628			133,698		$	95.74
Granted		—			—			—			—
Vested		(14,480	)		—			(14,480	)		98.42
Forfeited/canceled		—			(29,273	)		(29,273	)		110.27
Unvested restricted stock awards outstanding as of June 30, 2020 ⁽¹⁾		56,590			33,355			89,945		$	91.45
Unvested and expected to vest restricted stock awards outstanding as of June 30, 2020								58,037		$	84.75

(1)	Outstanding restricted stock units and restricted stock awards are based on the maximum payout of the targeted number of shares.

Summary of Stock-based Compensation Expense

Stock-based compensation

Stock-based compensation expense recognized for the three and six months ended June 30, 2020 and June 30, 2019, was as follows:

	Three months ended				Six months ended
	June 30,				June 30,
	2020		2019		2020		2019
Stock-based compensation expense by type of award:
Stock option plan awards	$	184	$	776	$	709	$	1,923
Restricted stock units and restricted stock awards		892		791		2,975		3,048
Employee stock purchase plan		201		212		377		394
Total stock-based compensation expense	$	1,277	$	1,779	$	4,061	$	5,365

For the three and six months ended June 30, 2020 and June 30, 2019, respectively, stock-based compensation expense recognized under ASC 718, included in cost of revenue, research and development expense, sales and marketing expense, and general and administrative expense was as follows:

	Three months ended				Six months ended
	June 30,				June 30,
	2020		2019		2020		2019
Cost of revenue	$	97	$	199	$	326	$	484
Research and development		173		227		493		604
Sales and marketing		459		336		1,071		1,026
General and administrative		548		1,017		2,171		3,251
Total stock-based compensation expense	$	1,277	$	1,779	$	4,061	$	5,365